By Mark De Belder2011-12-28T00:03:00
A new treatment available to combat valvular heart disease could be an opportunity to improve the care provided to those who would previously have been too ill for open heart surgery - and cut mortality rates in patients with the disease. Dr Mark De Belder explains.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud